查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945473

2026年卢克血液分离机全球市场报告

Leukapheresis Device Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，白血球分离设备的市场规模显着成长，预计2025年将达到7亿美元，到2026年将达到7.6亿美元，复合年增长率为8.6%。过去几年的增长可归因于白血病和自体免疫疾病发生率的上升、干细胞疗法的引入、血液细胞分离技术的进步、临床研究活动的增加以及医院血球分离术服务的扩展。

预计未来几年，白血球分离设备市场将维持强劲成长，2030年市场规模将达到10.1亿美元，复合年增长率（CAGR）为7.4%。预测期内的成长要素包括：对携带式白血球分离系统的需求、人工智慧和自动化技术在设备中的应用、生物製药研究的拓展、先进血球分离设备的监管核准以及精准医疗投资的增加。预测期内的关键趋势包括：个人化白血球分离疗法、微创血球分离技术、携带式和照护现场白血球分离设备、即时监测系统的整合以及自动化程度和工作流程效率的提高。

预计未来几年，血液相关疾病发生率的上升将推动白血球分离器市场的成长。血液相关疾病是指影响血球结构和功能的疾病，会导致氧气运输、免疫系统功能和血液凝固的问题。这些疾病发生率的上升与人口老化密切相关，因为老年人更容易患贫血、白血病和其他血液疾病。白血球分离器透过选择性地从血液中去除过量或异常的白血球来辅助治疗这些疾病。这有助于缓解症状并最大限度地减少白血病和自体免疫疾病的併发症。例如，根据澳洲非营利组织白血病基金会2024年3月发布的数据，约有19,500名澳洲人被诊断出罹患血液癌症，包括白血病、淋巴瘤和骨髓瘤。其中约43%的患者需要承担高额的自费治疗费用，42%的患者需要休假三个月以上。这凸显了血液疾病发生率较往年上升，以及对患者及其家庭造成的经济影响。因此，血液疾病的日益增多正在推动白血球分离器市场的扩张。

白血球分离设备市场的主要企业正加大对本地生产能力的投资，以改善治疗设备的可近性并配合国家医疗卫生策略。建立本地生产设施有助于提高供应链效率，降低进口依赖，并提升先进血液和细胞采集系统的成本效益和可用性。例如，2024年11月，美国医疗技术公司泰尔Terumo Corporation Blood & Cell Technologies, Inc.）与其中国子公司Terumo Medical Corp.产品（杭州）有限公司合作，在杭州启动在地化生产。该计画专注于生产关键的白血球分离产品，例如Trima Accel全自动血液采集系统和Spectra Optia血液分离系统，这些产品在中国广泛应用于治疗性血液分离、干细胞采集和血液成分分离等操作。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球卢克血液分离机市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 个人化白血球分离疗法
    • 微创血液分离技术
    • 携带式和照护现场白血球分离器
    • 即时监控系统集成
    • 自动化和工作流程效率

第五章 终端用户产业市场分析

  • 医院
  • 学术研究机构
  • 製药公司
  • 血液成分供应商
  • 血液中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球卢克血液分离设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球卢克血液分离设备市场规模、对比及成长率分析
  • 全球卢克血液分离设备市场表现：规模与成长，2020-2025年
  • 全球卢克血液分离设备市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依设备类型
  • 治疗性白血球分离、细胞分离、干细胞采集、研究应用、白血球分离柱及细胞分离装置、白血球分离抛弃式、血球分离装置
  • 按组件
  • 白血球分离器、采血组、医疗耗材、过滤器
  • 最终用户
  • 医院、学术研究机构、製药和生物技术公司、血液成分供应商、血站
  • 按类型细分：治疗性白血球分离术
  • 白血病治疗系统、败血症治疗用白血球清除装置、自体免疫疾病管理装置
  • 依类型细分：细胞分离术
  • 血小板分离器、淋巴球分离器、红血球分离器
  • 依类型细分：干细胞采集
  • 週边血干细胞（PBSC）采集装置、脐带血采集系统、骨髓干细胞分离系统
  • 按类型细分：研究用途
  • 用于研发的细胞分离系统、用于临床试验的血球分离平台、用于学术实验室的白血球分离器
  • 按类型细分：白血球分离柱和细胞分离装置
  • 吸附柱、膜细胞分离系统、离心细胞分离装置
  • 依类型细分：白血球分离用抛弃式产品
  • 输液管组件、针头和导管、收集袋
  • 按类型细分：血液分离机
  • 连续式血浆分离机、携带式或移动式血浆分离装置、间歇式血浆分离系统

第十章 区域与国家分析

  • 全球卢克血液分离设备市场：按地区、业绩和预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球卢克血液分离设备市场：依国家、性能及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 卢克血液分离机市场：竞争格局与市场份额，2024 年
  • 卢克血液分离设备市场：公司估值矩阵
  • 卢克血液分离设备市场：公司简介
    • Fresenius SE and Co. KGaA
    • Asahi Kasei Medical Co. Ltd
    • Baxter International Inc.
    • Grifols SA
    • TERUMO BCT INC.

第37章：其他领先和创新企业

  • Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年卢克血液分离设备市场：提供新机会的国家
  • 2030年卢克血液分离设备市场：提供新机会的细分市场
  • 2030年卢克血液分离设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME5MLDEV05_G26Q1

A leukapheresis device is a specialized medical tool designed to selectively isolate and collect white blood cells (leukocytes) from the blood of a patient or donor through centrifugation or filtration methods. It serves an essential function in therapies such as leukemia treatment, stem cell transplantation, and autoimmune disorder management, and is also utilized in clinical research and diagnostic procedures.

The primary categories of leukapheresis devices include therapeutic leukapheresis, cytapheresis, stem cell collection, research applications, leukapheresis columns and cell separators, leukapheresis disposables, and apheresis devices. Therapeutic leukapheresis is a medical technique employed to extract surplus or abnormal white blood cells from the bloodstream, aiming to alleviate symptoms or avoid related complications. These systems comprise various elements, including leukapheresis machines, blood collection sets, medical consumables, and filtration components. The diverse group of end users includes hospitals, academic and research organizations, pharmaceutical and biotechnology firms, blood centers, and providers of blood components.

Tariffs have influenced the leukapheresis device market by affecting the cost of imported medical equipment, consumables, and advanced apheresis components. This has increased production and operational costs, particularly impacting segments such as leukapheresis machines, disposable kits, and research-focused apheresis platforms in regions like North America and Europe. While the tariffs pose challenges in terms of supply chain delays, they also encourage local manufacturing and sourcing strategies, enabling some domestic players to capture market share and invest in innovation for cost-efficient leukapheresis solutions.

The leukapheresis device market research report is one of a series of new reports from The Business Research Company that provides leukapheresis device market statistics, including leukapheresis device industry global market size, regional shares, competitors with a leukapheresis device market share, detailed leukapheresis device market segments, market trends and opportunities, and any further data you may need to thrive in the leukapheresis device industry. This leukapheresis device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leukapheresis device market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.76 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising prevalence of leukemia and autoimmune disorders, adoption of stem cell therapies, advancements in blood cell separation technology, increasing clinical research activities, growth of hospital-based apheresis services.

The leukapheresis device market size is expected to see strong growth in the next few years. It will grow to $1.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to demand for portable leukapheresis systems, integration of ai and automation in devices, expansion of biopharmaceutical research, regulatory approvals for advanced apheresis devices, rising investments in precision medicine. Major trends in the forecast period include personalized leukapheresis treatments, minimally invasive apheresis techniques, portable and point-of-care leukapheresis devices, integration of real-time monitoring systems, enhanced automation and workflow efficiency.

The increasing incidence of blood-related disorders is expected to drive the growth of the leukapheresis device market in the coming years. Blood-related disorders are medical conditions that affect the structure or function of blood cells, leading to issues with oxygen transport, immune system performance, or blood clotting. The growing prevalence of these disorders is largely linked to an aging population, as older adults are more prone to conditions such as anemia, leukemia, and other hematological diseases. Leukapheresis devices support the treatment of these disorders by selectively removing excess or abnormal white blood cells from the blood, thereby helping to relieve symptoms and minimize complications in illnesses like leukemia and autoimmune disorders. For example, in March 2024, the Leukaemia Foundation, an Australia-based non-profit organization, reported that approximately 19,500 Australians were diagnosed with blood cancers, including leukemia, lymphoma, and myeloma, with nearly 43% facing substantial out-of-pocket treatment expenses and 42% needing more than three months off work. This highlights both the rising occurrence and the financial impact on patients and their families compared to previous years. Consequently, the growing prevalence of blood-related disorders is fueling the expansion of the leukapheresis device market.

Key players in the leukapheresis device market are increasingly investing in regional production capabilities to improve access to therapeutic devices and align with national healthcare strategies. Establishing local manufacturing facilities helps to streamline supply chains, reduce reliance on imports, and enhance the affordability and availability of advanced blood and cell collection systems. For instance, in November 2024, Terumo Blood and Cell Technologies, a US-based medical technology firm, collaborated with its China-based subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to initiate localized production in Hangzhou. This initiative focuses on producing vital leukapheresis products, such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, which are widely used in China for procedures including therapeutic apheresis, stem cell collection, and blood component separation.

In November 2025, Terumo Blood and Cell Technologies (Terumo BCT), a US-based medical technology company, joined forces with Santersus AG to advance an innovative therapeutic apheresis technology aimed at enhancing clinical outcomes for patients with sepsis. Through this collaboration, Terumo BCT and Santersus plan to integrate Santersus' NucleoCapture blood purification device with Terumo BCT's Spectra Optia(TM) Apheresis System to selectively remove neutrophil extracellular traps (NETs) from the blood, potentially lowering sepsis-related mortality and improving patient care. Santersus AG, based in Switzerland, specializes in therapeutic apheresis and develops medical devices for blood purification in critically ill patients.

Major companies operating in the leukapheresis device market are Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, Terumo Corporation

North America was the largest region in the leukapheresis device market in 2025. The regions covered in the leukapheresis device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the leukapheresis device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The leukapheresis device market consists of sales of leukapheresis software and monitoring systems, blood flow controllers and pumps, and centrifuge rotors and tubing sets. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukapheresis Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses leukapheresis device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukapheresis device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The leukapheresis device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Therapeutic Leukapheresis; Cytapheresis; Stem Cell Collection; Research Applications; Leukapheresis Columns and Cell Separators; Leukapheresis Disposables; Apheresis Devices
  • 2) By Component: Leukapheresis Machine; Blood Collection Set ; Medical Consumables ; Filters
  • 3) By End User: Hospitals; Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Blood Component Providers; Blood Centers
  • Subsegments:
  • 1) By Therapeutic Leukapheresis: Leukemia Treatment Systems; Sepsis Treatment Leukapheresis Units; Autoimmune Disease Management Devices
  • 2) By Cytapheresis: Plateletpheresis Devices; Lymphapheresis Units; Erythrocytapheresis Systems
  • 3) By Stem Cell Collection: Peripheral Blood Stem Cell (PBSC) Collection Devices; Umbilical Cord Blood Collection Systems; Bone Marrow Stem Cell Apheresis Systems
  • 4) By Research Applications: Cell Separation Systems for Research and Development; Clinical Trial Apheresis Platforms; Academic Laboratory Leukapheresis Devices
  • 5) By Leukapheresis Columns And Cell Separators: Adsorption Columns; Membrane-Based Cell Separation Systems; Centrifugal Cell Separators
  • 6) By Leukapheresis Disposables: Tubing Sets; Needles And Catheters; Collection Bags
  • 7) By Apheresis Devices: Continuous Flow Apheresis Machines; Portable Or Mobile Apheresis Units; Intermittent Flow Apheresis Systems
  • Companies Mentioned: Fresenius SE and Co. KGaA; Asahi Kasei Medical Co. Ltd; Baxter International Inc.; Grifols S.A.; TERUMO BCT INC.; Kaneka Corporation; Nikkiso Co. Ltd; Haemonetics Corporation; Miltenyi Biotec GmbH; Macopharma; B. Braun Melsungen AG; Kawasumi Laboratories Inc.; Beijing Zksk Technology Co. Ltd; Puriblood Medical Co. Ltd; Fresenius Kabi AG; JMS Co. Ltd; HemaCare Corporation; Medica Group PLC; LivaNova PLC; Cytiva; BioSafe Group SA; Terumo Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Leukapheresis Device Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Leukapheresis Device Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Leukapheresis Device Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Leukapheresis Device Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Personalized Leukapheresis Treatments
    • 4.2.2 Minimally Invasive Apheresis Techniques
    • 4.2.3 Portable And Point-Of-Care Leukapheresis Devices
    • 4.2.4 Integration Of Real-Time Monitoring Systems
    • 4.2.5 Enhanced Automation And Workflow Efficiency

5. Leukapheresis Device Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Academic Research Institutes
  • 5.3 Pharmaceutical Companies
  • 5.4 Blood Component Providers
  • 5.5 Blood Centers

6. Leukapheresis Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Leukapheresis Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Leukapheresis Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Leukapheresis Device Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Leukapheresis Device Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Leukapheresis Device Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Leukapheresis Device Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Leukapheresis Device Market Segmentation

  • 9.1. Global Leukapheresis Device Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Therapeutic Leukapheresis, Cytapheresis, Stem Cell Collection, Research Applications, Leukapheresis Columns and Cell Separators, Leukapheresis Disposables, Apheresis Devices
  • 9.2. Global Leukapheresis Device Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Leukapheresis Machine, Blood Collection Set, Medical Consumables, Filters
  • 9.3. Global Leukapheresis Device Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Blood Component Providers, Blood Centers
  • 9.4. Global Leukapheresis Device Market, Sub-Segmentation Of Therapeutic Leukapheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Leukemia Treatment Systems, Sepsis Treatment Leukapheresis Units, Autoimmune Disease Management Devices
  • 9.5. Global Leukapheresis Device Market, Sub-Segmentation Of Cytapheresis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plateletpheresis Devices, Lymphapheresis Units, Erythrocytapheresis Systems
  • 9.6. Global Leukapheresis Device Market, Sub-Segmentation Of Stem Cell Collection, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Peripheral Blood Stem Cell (PBSC) Collection Devices, Umbilical Cord Blood Collection Systems, Bone Marrow Stem Cell Apheresis Systems
  • 9.7. Global Leukapheresis Device Market, Sub-Segmentation Of Research Applications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell Separation Systems for Research and Development, Clinical Trial Apheresis Platforms, Academic Laboratory Leukapheresis Devices
  • 9.8. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Columns And Cell Separators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Adsorption Columns, Membrane-Based Cell Separation Systems, Centrifugal Cell Separators
  • 9.9. Global Leukapheresis Device Market, Sub-Segmentation Of Leukapheresis Disposables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tubing Sets, Needles And Catheters, Collection Bags
  • 9.10. Global Leukapheresis Device Market, Sub-Segmentation Of Apheresis Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Flow Apheresis Machines, Portable Or Mobile Apheresis Units, Intermittent Flow Apheresis Systems

10. Leukapheresis Device Market Regional And Country Analysis

  • 10.1. Global Leukapheresis Device Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Leukapheresis Device Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Leukapheresis Device Market

  • 11.1. Asia-Pacific Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Leukapheresis Device Market

  • 12.1. China Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Leukapheresis Device Market

  • 13.1. India Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Leukapheresis Device Market

  • 14.1. Japan Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Leukapheresis Device Market

  • 15.1. Australia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Leukapheresis Device Market

  • 16.1. Indonesia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Leukapheresis Device Market

  • 17.1. South Korea Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Leukapheresis Device Market

  • 18.1. Taiwan Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Leukapheresis Device Market

  • 19.1. South East Asia Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Leukapheresis Device Market

  • 20.1. Western Europe Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Leukapheresis Device Market

  • 21.1. UK Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Leukapheresis Device Market

  • 22.1. Germany Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Leukapheresis Device Market

  • 23.1. France Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Leukapheresis Device Market

  • 24.1. Italy Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Leukapheresis Device Market

  • 25.1. Spain Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Leukapheresis Device Market

  • 26.1. Eastern Europe Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Leukapheresis Device Market

  • 27.1. Russia Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Leukapheresis Device Market

  • 28.1. North America Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Leukapheresis Device Market

  • 29.1. USA Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Leukapheresis Device Market

  • 30.1. Canada Leukapheresis Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Leukapheresis Device Market

  • 31.1. South America Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Leukapheresis Device Market

  • 32.1. Brazil Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Leukapheresis Device Market

  • 33.1. Middle East Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Leukapheresis Device Market

  • 34.1. Africa Leukapheresis Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Leukapheresis Device Market, Segmentation By Device Type, Segmentation By Component, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Leukapheresis Device Market Regulatory and Investment Landscape

36. Leukapheresis Device Market Competitive Landscape And Company Profiles

  • 36.1. Leukapheresis Device Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Leukapheresis Device Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Leukapheresis Device Market Company Profiles
    • 36.3.1. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Asahi Kasei Medical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. TERUMO BCT INC. Overview, Products and Services, Strategy and Financial Analysis

37. Leukapheresis Device Market Other Major And Innovative Companies

  • Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva

38. Global Leukapheresis Device Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Leukapheresis Device Market

40. Leukapheresis Device Market High Potential Countries, Segments and Strategies

  • 40.1 Leukapheresis Device Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Leukapheresis Device Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Leukapheresis Device Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer